COVID-19 expedites India's focus on innovation within pharma
By MYBRANDBOOK
The COVID-19 pandemic has pushed India to expedite focus on pharma research and development (R&D) to become more independent. The hope of getting indigenous COVID-19 vaccines has boosted the government's confidence towards indigenous research and development and this momentum should continue, says GlobalData, a leading data analytics and research company.
India is expected to unveil a new Pharma Research and Development policy soon to incentivize scientists based on the monetization of their innovations. According to the Global Innovation Index, India has moved up four places to 48 in the overall ranking across sectors in 2020.
Moreover, the government is willing to focus on industry-academia linkage to translate research into the development and the commercialization of technologies while promoting research towards new drug discovery.
Prashant Khadayate, Pharma Analyst at GlobalData, comments: “India is working on infrastructure to accelerate R&D in India. Hopefully, the new policy will provide incentives that will accelerate R&D. It could act as a key milestone to turnaround the overall R&D environment within the Indian pharma industry.”
In 2019, the Department of Pharmaceuticals (DoP) outlined a drug discovery scheme. However, the production-linked incentive (PLI) scheme for the active pharmaceutical ingredients was prioritized over the drug discovery scheme during the COVID-19 pandemic. The DoP set up an inter-departmental committee to coordinate R&D activities undertaken by various top institutions such as the Indian Institutes of Technology (IITs), the National Institutes of Pharmaceutical Education and Research (NIPERs), and the Biotechnology Industry Research Assistance Council (BIRAC).
According to GlobalData’s Pharma Intelligence Center, Bharat Biotech (in partnership with the Indian Council of Medical Research (ICMR)) and Zydus Cadila are leading the race for indigenous vaccine development in India. Bharat Biotech vaccine Covaxin is in Phase III and the company has filed for its emergency use authorization (EUA), whereas Zydus Cadila’s vaccine ZyCoV-D is expected to enter Phase III in December 2020.
In July 2020, a first-of-its-kind Drug Discovery Hackathon project was initiated to develop an anti-COVID drug. This hackathon is a national initiative to support the drug discovery process and invited the participation of professionals, faculty, researchers, and students from varied fields like computer science, chemistry, pharmacy, medical sciences, basic sciences and biotechnology.
Mr Khadayate concludes: “Indigenous vaccines’ development progress by Indian companies in a short turnaround time has proven their capability in the innovation space on par with global companies. However, the government support will help in improving the overall environment towards research and development.”
The latest version of X helps prevent deepfakes on social medi
To combat deepfakes and shallowfakes, Elon Musk revealed a new update t...
India and Namibia collaborate on a payment system similar to U
Once operational, the platform will enable digital transactions in Namibia,...
Sebi issues show-cause notices to six Adani group firms
Sebi issued show-cause notices to six Adani Group firms, including Adani ...
Microsoft to build a new data centre to support Thailand's tec
Microsoft has revealed intentions to construct a regional data centre as w...
TVS ELECTRONICS LTD.
BEETEL TELETECH LTD.
RAMCO SYSTEMS Ltd.
IBALL WORLDWIDE PVT. LTD.
Technology Icons Of India 2023: Sridhar Vembu
Sridhar Vembu is an Indian billionaire business magnate and the Founde...
Technology Icons Of India 2023: Sunil Vachani
Sunil Vachani is the founder and chairman of India-listed Dixon Techno...
Technology Icons Of India 2023: Byju Raveendran
Byju Raveendran is the founder of edutech start-up Byju’s. Raveendra...
GeM maintains transparency in online procurement of goods & services
Created in a record time of five months, Government eMarketplace is a ...
NIC bridging the digital divide and supporting government in eGovernance
The National Informatics Centre (NIC) is an Indian government departme...
NPCI leading India towards Digital payments
The National Payments Corporation of India (NPCI) is an initiative tak...
Crayon Software Experts India Pvt Ltd
Crayon helps its customers build the commercial and technical foundati...
R P TECH INDIA
R P Tech is recognized for its diverse products portfolio, value-add...
ADITYA INFOTECH LTD.
Aditya Infotech Ltd. (AIL) – the technology arm of Aditya Group, is ...